Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target raised by analysts at Guggenheim from $64.00 to $70.00. They now have a "buy" rating on the stock.

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com